Bradley Paul Morgan Insider Trading $CYTK CYTOKINETICS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Bradley Paul Morgan.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Bradley Paul Morgan. Bradley Paul Morgan is SVP Drug Discovery & Early Dev in CYTOKINETICS INC ($CYTK).

Bradley Paul Morgan in CYTOKINETICS INC

Trading Symbol: CYTK
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bradley Paul Morgan: SVP Drug Discovery & Early Dev
Holdings: 63,107 shares
Current Value: $738,352
Latest Transaction: Sep 01 2017
$CYTK Market Capitalization: $461.88M
$CYTK Previous Close: $11.70

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Bradley Paul Morgan in CYTOKINETICS INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseM11.106957,7150
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseM11.106947,703695
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseM9.6511,552111,4770
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseM9.426175,8120
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseM7.9615,206121,0403,750
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseM6.6716,666111,16214,517
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseM6.301,0796,7980
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseM6.003,79522,7700
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseM11.102,63829,2820
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseM11.102,63929,2932,638
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseM9.6513,448129,7735,000
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseM9.4211,883111,9380
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseM7.962,29418,2608,750
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseM6.3013,92087,6960
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseM6.0021,204127,2240
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...SellS15.002,63839,57046,44149.1 K to 46.4 K (-5.38 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...BuyM11.102,63829,28249,07946.4 K to 49.1 K (+5.68 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...SellS15.0069510,42546,44147.1 K to 46.4 K (-1.47 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...BuyM11.106957,71547,13646.4 K to 47.1 K (+1.50 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...SellS15.002,63939,58546,44149.1 K to 46.4 K (-5.38 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...BuyM11.102,63929,29349,08046.4 K to 49.1 K (+5.68 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...SellS15.0069410,41046,44147.1 K to 46.4 K (-1.47 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...BuyM11.106947,70347,13546.4 K to 47.1 K (+1.49 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...SellS15.0011,883178,24546,44158.3 K to 46.4 K (-20.37 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...BuyM9.4211,883111,93858,32446.4 K to 58.3 K (+25.59 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...SellS15.006179,25546,44147.1 K to 46.4 K (-1.31 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...BuyM9.426175,81247,05846.4 K to 47.1 K (+1.33 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...SellS15.0013,920208,80046,44160.4 K to 46.4 K (-23.06 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...BuyM6.3013,92087,69660,36146.4 K to 60.4 K (+29.97 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...SellS15.001,07916,18546,44147.5 K to 46.4 K (-2.27 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...BuyM6.301,0796,79847,52046.4 K to 47.5 K (+2.32 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...SellS15.0021,204318,06046,44167.6 K to 46.4 K (-31.35 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...BuyM6.0021,204127,22467,64546.4 K to 67.6 K (+45.66 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...SellS15.003,79556,92546,44150.2 K to 46.4 K (-7.55 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...BuyM6.003,79522,77050,23646.4 K to 50.2 K (+8.17 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...SellS15.0013,448201,72046,44159.9 K to 46.4 K (-22.45 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...BuyM9.6513,448129,77359,88946.4 K to 59.9 K (+28.96 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...SellS15.0011,552173,28046,44158 K to 46.4 K (-19.92 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...BuyM9.6511,552111,47757,99346.4 K to 58 K (+24.87 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...SellS15.002,29434,41046,44148.7 K to 46.4 K (-4.71 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...BuyM7.962,29418,26048,73546.4 K to 48.7 K (+4.94 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...SellS15.0015,206228,09046,44161.6 K to 46.4 K (-24.67 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...BuyM7.9615,206121,04061,64746.4 K to 61.6 K (+32.74 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...SellS15.0016,666249,99046,44163.1 K to 46.4 K (-26.41 %)
Sep 01 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...BuyM6.6716,666111,16263,10746.4 K to 63.1 K (+35.89 %)
Mar 02 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA10.6013,537143,49213,537
Mar 02 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA10.606,46368,5086,463
Mar 02 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...GrantA0.0020,0002045,19425.2 K to 45.2 K (+79.38 %)
Mar 02 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Payment of ExerciseF10.605,98663,45225,19431.2 K to 25.2 K (-19.20 %)
Mar 02 2017CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...GrantA0.0015,0001531,18016.2 K to 31.2 K (+92.71 %)
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA40.861937,886193
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA20.221,03320,8871,033
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA18.4872113,324721
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA11.106947,7031,389
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA11.106957,715695
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA9.6511,552111,47711,552
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA9.426175,812617
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA7.9618,956150,89018,956
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA6.6731,183207,99131,183
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA6.301,0796,7981,079
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA6.003,79522,7703,795
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA42.245,000211,2005,000
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA40.863,106126,9113,106
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA20.222,10142,4822,101
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA18.484,27879,0577,611
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA18.483,33361,5943,333
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA11.102,63929,2935,277
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA11.102,63829,2822,638
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA9.6518,448178,02318,448
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA9.4211,883111,93811,883
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA7.9611,04487,91011,044
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA6.6718,817125,50918,817
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA6.3013,92087,69613,920
Feb 25 2016CYTKCYTOKINETICS INCMorgan Bradley PaulSVP Drug Discovery ...Option ExerciseA6.0021,204127,22421,204

Page:   1

Contact us | Follow us on Twitter